Evidence map›Paper›PMID 39114655›Full record

ArticleFrontiers in immunology2024

Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins.

Karen J Gonzalez, Kevin C Yim, Jorge C G Blanco, Marina S Boukhvalova, Eva-Maria Strauch

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Karen J GonzalezInstitute of Bioinformatics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, United States.
Kevin C YimSigmovir Biosystems, Inc., Rockville, MD, United States.
Jorge C G BlancoSigmovir Biosystems, Inc., Rockville, MD, United States.
Marina S BoukhvalovaSigmovir Biosystems, Inc., Rockville, MD, United States.
Eva-Maria StrauchInstitute of Bioinformatics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, United States.

Funding

Design of Antivirals and Immunogens Targeting ParamyxovirusesR01AI140245 · NIAID · WASHINGTON UNIVERSITY · PI STRAUCH, EVA-MARIA · 2018 to 2023
$1.9M
Purchase of a Thermo Fisher Scientific LTQ Orbitrap XL Mass SpectrometerS10RR028859 · NCRR · UNIVERSITY OF GEORGIA · PI AMSTER, I JONATHAN · 2011 to 2011
$832k
NCRR NIH HHS S10 RR028859NIAID NIH HHS R01 AI140245NICHD NIH HHS 75N94023F00001
6 · The paper itself

Abstract

Numerous enveloped viruses, such as coronaviruses, influenza, and respiratory syncytial virus (RSV), utilize class I fusion proteins for cell entry. During this process, the proteins transition from a prefusion to a postfusion state, undergoing substantial and irreversible conformational changes. The prefusion conformation has repeatedly shown significant potential in vaccine development. However, the instability of this state poses challenges for its practical application in vaccines. While non-native disulfides have been effective in maintaining the prefusion structure, identifying stabilizing disulfide bonds remains an intricate task. Here, we present a general computational approach to systematically identify prefusion-stabilizing disulfides. Our method assesses the geometric constraints of disulfide bonds and introduces a ranking system to estimate their potential in stabilizing the prefusion conformation. We hypothesized that disulfides restricting the initial stages of the conformational switch could offer higher stability to the prefusion state than those preventing unfolding at a later stage. The implementation of our algorithm on the RSV F protein led to the discovery of prefusion-stabilizing disulfides that supported our hypothesis. Furthermore, the evaluation of our top design as a vaccine candidate in a cotton rat model demonstrated robust protection against RSV infection, highlighting the potential of our approach for vaccine development.

Indexed as

DisulfidesViral Fusion ProteinsAnimalsComputer-Aided DesignHumansModels, MolecularProtein ConformationProtein StabilityRatsRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesDisulfidesRespiratory Syncytial Virus VaccinesViral Fusion Proteinsclass I fusion proteinscomputational modelingdisulfide designprefusion stabilizationvaccine development

Identifiers

PMID39114655
PMCPMC11303214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.